0.010054
0.005805
0.000000
0.000000
0.011610
0.000000
0.000000
0.000000
0.023759
0.00000
0.00000
0.00000
Griffith, D.L.
Scott, D.L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
6
90.00
90.00
120.00
99.460
99.460
42.090
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
93
878
883
10.1073/pnas.93.2.878
8570652
Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily.
1996
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
244
657
Crystallization and Preliminary Crystallographic Data of Recombinant Human Osteogenic Protein-1 (Hop-1)
1994
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
IMAGE PLATE
1993-11-30
RIGAKU
M
x-ray
1
1.5418
1.0
1.5418
15699.730
BONE MORPHOGENETIC PROTEIN-7
1
man
polymer
OSTEOGENIC PROTEIN-1, HOP-1, BMP-7
no
no
STGSKQRSQNRSKTPKNQEALRMANVAENSSSDQRQACKKHELYVSFRDLGWQDWIIAPEGYAAYYCEGECAFPLNSYMN
ATNHAIVQTLVHFINPETVPKPCCAPTQLNAISVLYFDDSSNVILKKYRNMVVRACGCH
STGSKQRSQNRSKTPKNQEALRMANVAENSSSDQRQACKKHELYVSFRDLGWQDWIIAPEGYAAYYCEGECAFPLNSYMN
ATNHAIVQTLVHFINPETVPKPCCAPTQLNAISVLYFDDSSNVILKKYRNMVVRACGCH
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Chinese hamster
Cricetulus
sample
REFERENCE, T.K. SAMPATH, ET AL. (1992) J. BIOL. CHEM. 267, 20452-20362
HOP-1 CDNA
9606
OVARY
Homo sapiens
HOP-1 CDNA
10029
Cricetulus griseus
3.83
60.
repository
Initial release
Version format compliance
Derived calculations
Version format compliance
1
0
1997-07-23
1
1
2008-03-24
1
2
2011-07-13
Y
1995-12-14
REL
n
1
1
A
n
2
2
A
n
3
3
A
n
4
4
A
n
5
5
A
n
6
6
A
n
7
7
A
n
8
8
A
n
9
9
A
n
10
10
A
n
11
11
A
n
12
12
A
n
13
13
A
n
14
14
A
n
15
15
A
n
16
16
A
n
17
17
A
n
18
18
A
n
19
19
A
n
20
20
A
n
21
21
A
n
22
22
A
n
23
23
A
n
24
24
A
n
25
25
A
n
26
26
A
n
27
27
A
n
28
28
A
n
29
29
A
n
30
30
A
n
31
31
A
n
32
32
A
n
33
33
A
n
34
34
A
n
35
35
A
GLN
36
n
36
GLN
36
A
ALA
37
n
37
ALA
37
A
CYS
38
n
38
CYS
38
A
LYS
39
n
39
LYS
39
A
LYS
40
n
40
LYS
40
A
HIS
41
n
41
HIS
41
A
GLU
42
n
42
GLU
42
A
LEU
43
n
43
LEU
43
A
TYR
44
n
44
TYR
44
A
VAL
45
n
45
VAL
45
A
SER
46
n
46
SER
46
A
PHE
47
n
47
PHE
47
A
ARG
48
n
48
ARG
48
A
ASP
49
n
49
ASP
49
A
LEU
50
n
50
LEU
50
A
GLY
51
n
51
GLY
51
A
TRP
52
n
52
TRP
52
A
GLN
53
n
53
GLN
53
A
ASP
54
n
54
ASP
54
A
TRP
55
n
55
TRP
55
A
ILE
56
n
56
ILE
56
A
ILE
57
n
57
ILE
57
A
ALA
58
n
58
ALA
58
A
PRO
59
n
59
PRO
59
A
GLU
60
n
60
GLU
60
A
GLY
61
n
61
GLY
61
A
TYR
62
n
62
TYR
62
A
ALA
63
n
63
ALA
63
A
ALA
64
n
64
ALA
64
A
TYR
65
n
65
TYR
65
A
TYR
66
n
66
TYR
66
A
CYS
67
n
67
CYS
67
A
GLU
68
n
68
GLU
68
A
GLY
69
n
69
GLY
69
A
GLU
70
n
70
GLU
70
A
CYS
71
n
71
CYS
71
A
ALA
72
n
72
ALA
72
A
PHE
73
n
73
PHE
73
A
PRO
74
n
74
PRO
74
A
LEU
75
n
75
LEU
75
A
ASN
76
n
76
ASN
76
A
SER
77
n
77
SER
77
A
TYR
78
n
78
TYR
78
A
MET
79
n
79
MET
79
A
ASN
80
n
80
ASN
80
A
ALA
81
n
81
ALA
81
A
THR
82
n
82
THR
82
A
ASN
83
n
83
ASN
83
A
HIS
84
n
84
HIS
84
A
ALA
85
n
85
ALA
85
A
ILE
86
n
86
ILE
86
A
VAL
87
n
87
VAL
87
A
GLN
88
n
88
GLN
88
A
THR
89
n
89
THR
89
A
LEU
90
n
90
LEU
90
A
VAL
91
n
91
VAL
91
A
HIS
92
n
92
HIS
92
A
PHE
93
n
93
PHE
93
A
ILE
94
n
94
ILE
94
A
ASN
95
n
95
ASN
95
A
PRO
96
n
96
PRO
96
A
GLU
97
n
97
GLU
97
A
THR
98
n
98
THR
98
A
VAL
99
n
99
VAL
99
A
PRO
100
n
100
PRO
100
A
LYS
101
n
101
LYS
101
A
PRO
102
n
102
PRO
102
A
CYS
103
n
103
CYS
103
A
CYS
104
n
104
CYS
104
A
ALA
105
n
105
ALA
105
A
PRO
106
n
106
PRO
106
A
THR
107
n
107
THR
107
A
GLN
108
n
108
GLN
108
A
LEU
109
n
109
LEU
109
A
ASN
110
n
110
ASN
110
A
ALA
111
n
111
ALA
111
A
ILE
112
n
112
ILE
112
A
SER
113
n
113
SER
113
A
VAL
114
n
114
VAL
114
A
LEU
115
n
115
LEU
115
A
TYR
116
n
116
TYR
116
A
PHE
117
n
117
PHE
117
A
ASP
118
n
118
ASP
118
A
ASP
119
n
119
ASP
119
A
SER
120
n
120
SER
120
A
SER
121
n
121
SER
121
A
ASN
122
n
122
ASN
122
A
VAL
123
n
123
VAL
123
A
ILE
124
n
124
ILE
124
A
LEU
125
n
125
LEU
125
A
LYS
126
n
126
LYS
126
A
LYS
127
n
127
LYS
127
A
TYR
128
n
128
TYR
128
A
ARG
129
n
129
ARG
129
A
ASN
130
n
130
ASN
130
A
MET
131
n
131
MET
131
A
VAL
132
n
132
VAL
132
A
VAL
133
n
133
VAL
133
A
ARG
134
n
134
ARG
134
A
ALA
135
n
135
ALA
135
A
CYS
136
n
136
CYS
136
A
GLY
137
n
137
GLY
137
A
CYS
138
n
138
CYS
138
A
HIS
139
n
139
HIS
139
A
author_and_software_defined_assembly
PISA,PQS
2
dimeric
2370
-26
11690
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-0.5000000000
0.8660254038
0.0000000000
0.8660254038
0.5000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
4_555
y,x,-z
crystal symmetry operation
0.0000000000
0.0000000000
0.0000000000
A
O
LYS
39
A
O
LYS
39
A
N
GLU
68
A
N
GLU
68
A
O
VAL
45
A
O
VAL
45
A
N
TYR
62
A
N
TYR
62
A
O
ILE
112
A
O
ILE
112
A
N
TYR
128
A
N
TYR
128
A
O
CYS
103
A
O
CYS
103
A
N
HIS
139
A
N
HIS
139
1
A
SER
1
A
SER
1
1
Y
1
A
THR
2
A
THR
2
1
Y
1
A
GLY
3
A
GLY
3
1
Y
1
A
SER
4
A
SER
4
1
Y
1
A
LYS
5
A
LYS
5
1
Y
1
A
GLN
6
A
GLN
6
1
Y
1
A
ARG
7
A
ARG
7
1
Y
1
A
SER
8
A
SER
8
1
Y
1
A
GLN
9
A
GLN
9
1
Y
1
A
ASN
10
A
ASN
10
1
Y
1
A
ARG
11
A
ARG
11
1
Y
1
A
SER
12
A
SER
12
1
Y
1
A
LYS
13
A
LYS
13
1
Y
1
A
THR
14
A
THR
14
1
Y
1
A
PRO
15
A
PRO
15
1
Y
1
A
LYS
16
A
LYS
16
1
Y
1
A
ASN
17
A
ASN
17
1
Y
1
A
GLN
18
A
GLN
18
1
Y
1
A
GLU
19
A
GLU
19
1
Y
1
A
ALA
20
A
ALA
20
1
Y
1
A
LEU
21
A
LEU
21
1
Y
1
A
ARG
22
A
ARG
22
1
Y
1
A
MET
23
A
MET
23
1
Y
1
A
ALA
24
A
ALA
24
1
Y
1
A
ASN
25
A
ASN
25
1
Y
1
A
VAL
26
A
VAL
26
1
Y
1
A
ALA
27
A
ALA
27
1
Y
1
A
GLU
28
A
GLU
28
1
Y
1
A
ASN
29
A
ASN
29
1
Y
1
A
SER
30
A
SER
30
1
Y
1
A
SER
31
A
SER
31
1
Y
1
A
SER
32
A
SER
32
1
Y
1
A
ASP
33
A
ASP
33
1
Y
1
A
GLN
34
A
GLN
34
1
Y
1
A
ARG
35
A
ARG
35
1
Y
1
A
GLU
42
12.67
1
A
TYR
44
11.12
1
A
VAL
45
12.60
1
A
ASP
49
17.81
1
A
TRP
55
14.50
1
A
ILE
56
-13.16
1
A
ILE
57
11.66
1
A
ALA
58
-11.58
1
A
PHE
73
15.50
1
A
ALA
85
11.05
1
A
VAL
91
12.43
1
A
PRO
102
-10.21
1
A
LEU
109
-14.68
1
A
VAL
123
-10.37
1
A
CYS
136
-10.42
1
A
ARG
129
0.095
SIDE CHAIN
1
A
ARG
134
0.248
SIDE CHAIN
1
A
TRP
52
-64.51
19.70
1
A
TYR
65
63.72
173.88
1
A
TYR
78
-81.65
47.59
1
A
MET
79
-154.22
6.04
1
A
ASN
80
22.96
96.27
1
A
ASN
95
-157.97
78.50
1
A
ASP
118
-67.98
-178.51
1
A
ASP
119
-52.29
-178.81
1
A
SER
120
68.50
-23.63
1
A
ASN
130
72.46
43.08
28.48
LOOP REGION (RESIDUES 118 - 122) IS DISORDERED AND MODELED
STEREOCHEMICALLY.
NOTE THAT RESIDUE 59 IS DESCRIBED AS TRANS IN THE PAPER
CITED ON JRNL RECORDS ABOVE BUT THE CURRENT MODEL
PRESENTED IN THIS ENTRY HAS RESIDUE 59 AS CIS.
0.308
0.227
2.8
10.
5418
1
2.0
0.25
2.8
10.
0
828
0
0
828
0.008
0.030
0.025
0.050
0.138
0.100
0.045
0.100
0.211
1.00
0.185
1.0
0.250
1.0
0.194
1.0
23.2
30.
25.9
50.0
35.1
50.0
1BMP
5502
2.
0.067
1
2.6
87.
data collection
R-AXIS
SOFTWARE
data reduction
R-AXIS
SOFTWARE
model building
X-PLOR
refinement
PROFFT
refinement
X-PLOR
data scaling
R-AXIS
phasing
X-PLOR
BONE MORPHOGENETIC PROTEIN-7
BONE MORPHOGENETIC PROTEIN-7
1
N
N
A
HIS
84
A
HIS
84
HELX_P
A
PHE
93
A
PHE
93
1
1
10
disulf
2.022
A
CYS
38
A
SG
CYS
38
1_555
A
CYS
104
A
SG
CYS
104
1_555
disulf
2.054
A
CYS
67
A
SG
CYS
67
1_555
A
CYS
136
A
SG
CYS
136
1_555
disulf
2.014
A
CYS
71
A
SG
CYS
71
1_555
A
CYS
138
A
SG
CYS
138
1_555
disulf
1.948
A
CYS
103
A
SG
CYS
103
1_555
A
CYS
103
A
SG
CYS
103
4_555
TRANSFORMING GROWTH FACTOR
MORPHOGEN, TRANSFORMING GROWTH FACTOR, CYTOKINE, BONE, CARTILAGE, GLYCOPROTEIN
A
ALA
58
A
ALA
58
1
A
PRO
59
A
PRO
59
-27.14
A
PHE
73
A
PHE
73
1
A
PRO
74
A
PRO
74
20.83
BMP7_HUMAN
UNP
1
1
P18075
MHVRSLRAAAPHSFVALWAPLFLLRSALADFSLDNEVHSSFIHRRLRSQERREMQREILSILGLPHRPRPHLQGKHNSAP
MFMLDLYNAMAVEEGGGPGGQGFSYPYKAVFSTQGPPLASLQDSHFLTDADMVMSFVNLVEHDKEFFHPRYHHREFRFDL
SKIPEGEAVTAAEFRIYKDYIRERFDNETFRISVYQVLQEHLGRESDLFLLDSRTLWASEEGWLVFDITATSNHWVVNPR
HNLGLQLSVETLDGQSINPKLAGLIGRHGPQNKQPFMVAFFKATEVHFRSIRSTGSKQRSQNRSKTPKNQEALRMANVAE
NSSSDQRQACKKHELYVSFRDLGWQDWIIAPEGYAAYYCEGECAFPLNSYMNATNHAIVQTLVHFINPETVPKPCCAPTQ
LNAISVLYFDDSSNVILKKYRNMVVRACGCH
293
431
1BMP
1
139
P18075
A
1
1
139
2
2
2
2
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
LYS
39
A
LYS
39
A
HIS
41
A
HIS
41
A
TYR
66
A
TYR
66
A
GLU
68
A
GLU
68
A
TYR
44
A
TYR
44
A
SER
46
A
SER
46
A
GLY
61
A
GLY
61
A
ALA
63
A
ALA
63
A
ILE
112
A
ILE
112
A
PHE
117
A
PHE
117
A
VAL
123
A
VAL
123
A
TYR
128
A
TYR
128
A
CYS
103
A
CYS
103
A
GLN
108
A
GLN
108
A
ALA
135
A
ALA
135
A
HIS
139
A
HIS
139
154
P 32 2 1